Cargando…

The Role of Osimertinib in Treatment Naïve Epidermal Growth Factor Receptor–Mutated Stage IIIB or IV Non–Small-Cell Lung Cancer Patients

Detalles Bibliográficos
Autores principales: Uprety, Dipesh, Bista, Amir, Vallatharasu, Yazhini, Arjyal, Lubina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5989053/
https://www.ncbi.nlm.nih.gov/pubmed/29887733
http://dx.doi.org/10.1177/1179554918779585
_version_ 1783329385187639296
author Uprety, Dipesh
Bista, Amir
Vallatharasu, Yazhini
Arjyal, Lubina
author_facet Uprety, Dipesh
Bista, Amir
Vallatharasu, Yazhini
Arjyal, Lubina
author_sort Uprety, Dipesh
collection PubMed
description
format Online
Article
Text
id pubmed-5989053
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-59890532018-06-08 The Role of Osimertinib in Treatment Naïve Epidermal Growth Factor Receptor–Mutated Stage IIIB or IV Non–Small-Cell Lung Cancer Patients Uprety, Dipesh Bista, Amir Vallatharasu, Yazhini Arjyal, Lubina Clin Med Insights Oncol Perspective SAGE Publications 2018-06-04 /pmc/articles/PMC5989053/ /pubmed/29887733 http://dx.doi.org/10.1177/1179554918779585 Text en © The Author(s) 2018 http://www.creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Perspective
Uprety, Dipesh
Bista, Amir
Vallatharasu, Yazhini
Arjyal, Lubina
The Role of Osimertinib in Treatment Naïve Epidermal Growth Factor Receptor–Mutated Stage IIIB or IV Non–Small-Cell Lung Cancer Patients
title The Role of Osimertinib in Treatment Naïve Epidermal Growth Factor Receptor–Mutated Stage IIIB or IV Non–Small-Cell Lung Cancer Patients
title_full The Role of Osimertinib in Treatment Naïve Epidermal Growth Factor Receptor–Mutated Stage IIIB or IV Non–Small-Cell Lung Cancer Patients
title_fullStr The Role of Osimertinib in Treatment Naïve Epidermal Growth Factor Receptor–Mutated Stage IIIB or IV Non–Small-Cell Lung Cancer Patients
title_full_unstemmed The Role of Osimertinib in Treatment Naïve Epidermal Growth Factor Receptor–Mutated Stage IIIB or IV Non–Small-Cell Lung Cancer Patients
title_short The Role of Osimertinib in Treatment Naïve Epidermal Growth Factor Receptor–Mutated Stage IIIB or IV Non–Small-Cell Lung Cancer Patients
title_sort role of osimertinib in treatment naïve epidermal growth factor receptor–mutated stage iiib or iv non–small-cell lung cancer patients
topic Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5989053/
https://www.ncbi.nlm.nih.gov/pubmed/29887733
http://dx.doi.org/10.1177/1179554918779585
work_keys_str_mv AT upretydipesh theroleofosimertinibintreatmentnaiveepidermalgrowthfactorreceptormutatedstageiiiborivnonsmallcelllungcancerpatients
AT bistaamir theroleofosimertinibintreatmentnaiveepidermalgrowthfactorreceptormutatedstageiiiborivnonsmallcelllungcancerpatients
AT vallatharasuyazhini theroleofosimertinibintreatmentnaiveepidermalgrowthfactorreceptormutatedstageiiiborivnonsmallcelllungcancerpatients
AT arjyallubina theroleofosimertinibintreatmentnaiveepidermalgrowthfactorreceptormutatedstageiiiborivnonsmallcelllungcancerpatients
AT upretydipesh roleofosimertinibintreatmentnaiveepidermalgrowthfactorreceptormutatedstageiiiborivnonsmallcelllungcancerpatients
AT bistaamir roleofosimertinibintreatmentnaiveepidermalgrowthfactorreceptormutatedstageiiiborivnonsmallcelllungcancerpatients
AT vallatharasuyazhini roleofosimertinibintreatmentnaiveepidermalgrowthfactorreceptormutatedstageiiiborivnonsmallcelllungcancerpatients
AT arjyallubina roleofosimertinibintreatmentnaiveepidermalgrowthfactorreceptormutatedstageiiiborivnonsmallcelllungcancerpatients